Extreme Networks Inc. (NASDAQ:EXTR) on Tuesday reported a loss of $19.3 million in its fiscal first quarter. The San Jose, California-based company said it had a loss of 20 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 1 cent per share. Extreme Networks Inc. (NASDAQ:EXTR) in last trading activity moved up 10.00% to close at $3.63. Company weekly performance is 20.60% while its quarterly performance stands at -22.77%. Extreme Networks Inc. (NASDAQ:EXTR) is -55.41% away from its 52 week high.

The Dow Chemical Company (NYSE:DOW) Director Paul Polman bought 21,500 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were purchased at an average price of $46.56 per share, for a total transaction of $1,001,040.00. On last trading day The Dow Chemical Company (NYSE:DOW) fell -1.25% to close at $47.38. Its volatility for the week is 2.76% while volatility for the month is 3.53%. DOW’s sales growth for past 5 years was -0.10% and its EPS growth for past 5 years was 42.10%. The Dow Chemical Company (NYSE:DOW) monthly performance is -9.65%.

On October 16, PhotoMedex (NASDAQ:PHMD) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 2,946,995 shares, a growth of 42.2% from the September 15th total of 2,072,881 shares, AmericanBankingNews.com reports. Approximately 25.9% of the shares of the company are sold short. Based on an average daily volume of 162,634 shares, the days-to-cover ratio is currently 18.1 days. On last trading day PhotoMedex, Inc. (NASDAQ:PHMD) fell -8.17% to close at $3.82. Its volatility for the week is 6.86% while volatility for the month is 6.47%. PHMD’s sales growth for past 5 years was 45.20% and its EPS growth for past 5 years was 16.20%. PhotoMedex, Inc. (NASDAQ:PHMD) monthly performance is -38.39%.

CytRx Corporation (NASDAQ:CYTR) announced that a paper, titled “Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma,” has been published online in Neoplasia (Volume 16, Issue 10). CytRx Corporation (NASDAQ:CYTR) has 21.92% insider ownership while its institutional ownership stands at 43.50%. In last trading activity company’s stock closed at $2.87.

Shares of Allied Nevada Gold Corp. (NYSEMKT:ANV) were the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 35,304,080 shares, a decline of 1.2% from the September 30th total of 35,715,063 shares, American Banking and Market News reports. Based on an average trading volume of 3,596,940 shares, the days-to-cover ratio is presently 9.8 days. Currently, 36.7% of the company’s stock are sold short. On Wednesday shares of Allied Nevada Gold Corp. (NYSEMKT:ANV) closed at $1.65.